The results, while preliminary, indicate that GLP-1s could be a valuable add-on treatment for some people with migraines who haven’t responded to other medications, the study authors say.

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this widespread impact, many sufferers find current preventive treatments ...

Called liraglutide, the drug is in the same family as the blockbuster weight-loss drugs Ozempic and Wegovy, which have taken the world by storm. In a small trial of 31 people with chronic migraines ...

Researchers say GLP-1 medicines might be able to help with migraines.

Around five million Australians suffer from migraines, with women three times more likely to be affected than men ...

Debilitating headaches are reducing their quality of life, but doctors say taking these steps can help.

Despite a multitude of treatment options ... reduced the number of days with migraines by half. These are the same type of drugs as those used for weight loss and diabetes, like Ozempic, which work by ...

Ozempic-like drugs used to treat type 2 diabetes and obesity may also treat migraine, even when the medications don't trigger weight loss, early research suggests. A preliminary report, published ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

Doctors are regularly overlooking a common hormone-driven cause of high blood pressure -- primary aldosteronism -- ...

A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few years, though they do have some drawbacks.